ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile
ACS Publications Bio & Med Chem Content

@acsbiomed

Journal articles, eBooks, news, events, and other information about biological and medicinal chemistry from @ACSPublications, a division of @AmerChemSociety

ID: 419690948

linkhttp://pubs.acs.org calendar_today23-11-2011 17:25:13

4,4K Tweet

14,14K Followers

354 Following

ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

⏰ Deadline Approaching ⏰ DUE May 31 Submit your manuscripts to the upcoming special issue in #ACSMedChemLett highlighting the exciting collaborations in #DrugDiscovery happening across the academic and industrial divide 🤝 More information ➡ go.acs.org/czU

⏰ Deadline Approaching ⏰ DUE May 31

Submit your manuscripts to the upcoming special issue in #ACSMedChemLett highlighting the exciting collaborations in #DrugDiscovery happening across the academic and industrial divide 🤝

More information ➡ go.acs.org/czU
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

The May issue of #ACSMedChemLett is out today! Dr. Amanda Dombrowski highlights three must read articles this month In this Issue. go.acs.org/czZ

The May issue of #ACSMedChemLett is out today! Dr. Amanda Dombrowski highlights three must read articles this month In this Issue.

go.acs.org/czZ
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

Check out the latest issue of #JMedChem! go.acs.org/cA4 The cover image depicts Pt complexes derived from formononetin activate death receptors and natural killer cells suppressing triple-negative breast cancer.

Check out the latest issue of #JMedChem!

go.acs.org/cA4

The cover image depicts Pt complexes derived from formononetin activate death receptors and natural killer cells suppressing triple-negative breast cancer.
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

Chemical correlation of protein binding characteristics in modified oligonucleotides: a perspective on current understanding and the way ahead in #JMedChem go.acs.org/cA8

Chemical correlation of protein binding characteristics in modified oligonucleotides: a perspective on current understanding and the way ahead in #JMedChem 

go.acs.org/cA8
ACS Publications (@acspublications) 's Twitter Profile Photo

A recent study reveals the hidden dangers of neonicotinoid pesticides on honeybee colonies, with effects on foraging efficiency and overall health. Read more on ACS Axial: go.acs.org/cAe

ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

The May issue of #ACSInfectiousDiseases is out today! go.acs.org/cAi In the cover story by Karn et al., the authors demonstrate the therapeutic potential of heparin-binding proteins.

The May issue of #ACSInfectiousDiseases is out today!

go.acs.org/cAi

In the cover story by Karn et al., the authors demonstrate the therapeutic potential of heparin-binding proteins.
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

#ACSBioMedAu 2024 Rising Stars Special Issue update: 📑 Leveraging the Capsular Polysaccharide Synthesis Pathway in Streptococcus pneumoniae as a Genetic Glycoengineering Platform Dr. (Chris) Lok-To Sham, National University of Singapore Free read ➡ go.acs.org/cAJ

#ACSBioMedAu 2024 Rising Stars Special Issue update:

📑 Leveraging the Capsular Polysaccharide Synthesis Pathway in Streptococcus pneumoniae as a Genetic Glycoengineering Platform

Dr. (Chris) Lok-To Sham, National University of Singapore

Free read ➡ go.acs.org/cAJ
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

A new Perspective in #JMedChem shares lived experiences and strategies to overcome Afrocentric barriers in advancing medicinal chemistry in Africa. go.acs.org/cAY

A new Perspective in #JMedChem shares lived experiences and strategies to overcome Afrocentric barriers in advancing medicinal chemistry in Africa. 

go.acs.org/cAY
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

Joint Special Issue from #JMedChem and #ACSMedChemLett Many Faces of Medicinal Chemistry, celebrating the exciting research happening around the world from both academic and industrial institutions. Read here ➡ go.acs.org/cBa!

Joint Special Issue from #JMedChem and #ACSMedChemLett

Many Faces of Medicinal Chemistry, celebrating the exciting research happening around the world from both academic and industrial institutions.

Read here ➡ go.acs.org/cBa!
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

New collection from #JMedChem highlights the best examples of the Drug Annotations article type from the past few years 🎉 Check it out ➡ go.acs.org/cBy

New collection from #JMedChem highlights the best examples of the Drug Annotations article type from the past few years 🎉

Check it out ➡ go.acs.org/cBy
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

We’re delighted to announce that John T. Ngo Ph.D. is the recipient of the 2025 ACS Synthetic Biology Young Innovator Award. Find out more about John here: go.acs.org/cBR

We’re delighted to announce that John T. Ngo Ph.D. is the recipient of the 2025 ACS Synthetic Biology Young Innovator Award. 

Find out more about John here: go.acs.org/cBR
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

📢 #BioconjugateChemistry is putting together an upcoming special issue on Site-Specific Chemistry! Organized by Associate Editor Gonçalo Bernardes and Guest Editor Aldrin Vasco Find out if your research fits ➡ go.acs.org/cBU

📢 #BioconjugateChemistry is putting together an upcoming special issue on Site-Specific Chemistry!

Organized by Associate Editor Gonçalo Bernardes and Guest Editor Aldrin Vasco

Find out if your research fits ➡ go.acs.org/cBU
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

Meet Karen Allen and Jianjun Cao, Winners of the 2025 Gordon Hammes Awards from #Biochemistry and @ACSBiol! Read their new interviews here: go.acs.org/cC5

Meet Karen Allen and Jianjun Cao, Winners of the 2025 Gordon Hammes Awards from #Biochemistry and @ACSBiol! 

Read their new interviews here: go.acs.org/cC5
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

⏰ Deadline Approaching ⏰ DUE May 31 Submit your manuscripts to the upcoming special issue in #ACSMedChemLett highlighting the exciting collaborations in #DrugDiscovery happening across the academic and industrial divide 🤝 More information ➡ go.acs.org/cCO

⏰ Deadline Approaching ⏰ DUE May 31

Submit your manuscripts to the upcoming special issue in #ACSMedChemLett highlighting the exciting collaborations in #DrugDiscovery happening across the academic and industrial divide 🤝

More information ➡ go.acs.org/cCO
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

📢 New Special Issue from #ACSInfectiousDiseases #JMedChem and #ACSMedChemLett 🍄 Fungal Pathogens: Life Cycle, Infection, Host Immunity and Drug Discovery Read the issue ➡ pubs.acs.org/page/si/fungal…

📢 New Special Issue from #ACSInfectiousDiseases #JMedChem and #ACSMedChemLett

🍄 Fungal Pathogens: Life Cycle, Infection, Host Immunity and Drug Discovery

Read the issue ➡ pubs.acs.org/page/si/fungal…
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

Meet Dr. Han Xiao, the recipient of the 2025 Bioconjugate Chemistry Young Investigator Award! Learn more about Dr. Xiao - his history with Bioconjugate Chemistry, research collaborators, and advice for starting a new lab here: go.acs.org/cDy

Meet Dr. Han Xiao, the recipient of the 2025 Bioconjugate Chemistry Young Investigator Award!

Learn more about Dr. Xiao - his history with Bioconjugate Chemistry, research collaborators, and advice for starting a new lab here: go.acs.org/cDy
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

Discovery of INCB126503, a selective FGFR2/3 inhibitor with gatekeeper mutant coverage and clean PK/safety, published in ACS Med Chem Lett. #oncology #medchem #FGFR go.acs.org/cDK

Discovery of INCB126503, a selective FGFR2/3 inhibitor with gatekeeper mutant coverage and clean PK/safety, published in <a href="/ACSMedChemLett/">ACS Med Chem Lett</a>. #oncology #medchem #FGFR 

go.acs.org/cDK